Skip to content
Pretest - Tumor Board Tuesday (ID: i788)
*
1.
Please list your last name and zip code:
(Required.)
Last name:
ZIP/Postal Code:
*
2.
What is your specialty?
(Required.)
*
3.
How many patients with colorectal cancer do you treat each week?
(Required.)
1 to 10
11 to 25
26 to 50
I am not directly involved in patient care
*
4.
What is the clinical significance of a tumor with an NRG1 fusion?
(Required.)
Potential benefit from platinum-based chemotherapy and PARP inhibitors
Potential benefit from blockade of the HER pathway
Potential benefit from immune checkpoint blockade
Potential benefit from larotrectinib/entrectinib
*
5.
Approximately what percentage of solid tumors harbor NRG1 fusions?
(Required.)
20%
10%
1%
0.2%